OTC Antimicrobial Resistance Study Subject Of FDA, NIH, CDC "Action Plan"
This article was originally published in The Rose Sheet
Executive Summary
A coalition of federal agencies will conduct an evaluation of OTC drug antimicrobial handwashes to assess whether such products could cause long-term bacterial resistance, according to a draft report issued by FDA, the Centers for Disease Control and Prevention and the National Institutes of Health June 22.
You may also be interested in...
Antimicrobial action plan
Evaluation of benefits/risks of incorporating antimicrobial disinfectants or chemicals into consumer products such as soap included in final interdepartmental antimicrobial resistance action plan unveiled by HHS Jan. 18. Although not specified in the final version, a draft released in June said agencies likely will consider whether such products "have any efficacy in reducing infection" and if they "play a role in promoting drug resistance" (1"The Rose Sheet" June 26, 2000, p. 8). Developed by the Task Force on Antimicrobial Resistance, the plan designates priorities, identifies responsible agencies and creates timelines for facilitating surveillance, prevention and control, research and product development to address antimicrobial resistance. CDC, NIH and FDA are leading task force of 10 agencies and departments
Antimicrobial action plan
Evaluation of benefits/risks of incorporating antimicrobial disinfectants or chemicals into consumer products such as soap included in final interdepartmental antimicrobial resistance action plan unveiled by HHS Jan. 18. Although not specified in the final version, a draft released in June said agencies likely will consider whether such products "have any efficacy in reducing infection" and if they "play a role in promoting drug resistance" (1"The Rose Sheet" June 26, 2000, p. 8). Developed by the Task Force on Antimicrobial Resistance, the plan designates priorities, identifies responsible agencies and creates timelines for facilitating surveillance, prevention and control, research and product development to address antimicrobial resistance. CDC, NIH and FDA are leading task force of 10 agencies and departments
Pediculicide Resistance Not Well Understood - Lancet Editorial
The mechanism by which head lice become resistant to pediculicides needs further study, Howard Maibach, MD, University of California at San Francisco, et al., suggest in the Aug. 12 issue of The Lancet.